34(top 100%)
PR articles
2.5K(top 10%)
PR citations
23(top 100%)
PR h-index
26(top 100%)
h-index
38
documents
3.7K
doc citations
899
citing journals
100
times ranked

Publications

34 PR articles • 2,650 PR citations • Sorted by year • Download PDF (PDF by citations)
Sort: Year | PR Citations
#ArticleIFPR CitationsLinks
1Copper Drives Remodeling of Metabolic State and Progression of Clear Cell Renal Cell Carcinoma
Cancer Discovery, 2025, 15, 401-426
25.69Citations (PDF)
2Coordinated Targeting of S6K1/2 and AXL Disrupts Pyrimidine Biosynthesis in PTEN-Deficient Glioblastoma
Cancer Research Communications, 2024, 4, 2215-2227
2.92Citations (PDF)
3Ferroptosis: A Specific Vulnerability of RAS-Driven Cancers?
Frontiers in Oncology, 2022, 12,
2.716Citations (PDF)
4Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancer
Nature Communications, 2022, 13,
13.9137Citations (PDF)
5Medium-Chain Acyl-CoA Dehydrogenase Protects Mitochondria from Lipid Peroxidation in Glioblastoma
Cancer Discovery, 2021, 11, 2904-2923
25.649Citations (PDF)
6Lipid Metabolism Regulates Oxidative Stress and Ferroptosis in RAS-Driven Cancers: A Perspective on Cancer Progression and Therapy
Frontiers in Molecular Biosciences, 2021, 8,
3.666Citations (PDF)
7The aryl hydrocarbon receptor regulates nucleolar activity and protein synthesis in MYC-expressing cells
Genes and Development, 2018, 32, 1303-1308
4.842Citations (PDF)
8Focal Adhesion Kinase Regulates the DNA Damage Response and Its Inhibition Radiosensitizes Mutant <i>KRAS</i> Lung Cancer
Clinical Cancer Research, 2016, 22, 5851-5863
6.883Citations (PDF)
9PIAS1 Promotes Lymphomagenesis through MYC Upregulation
Cell Reports, 2016, 15, 2266-2278
6.446Citations (PDF)
10PIAS1-FAK Interaction Promotes the Survival and Progression of Non-Small Cell Lung Cancer
Neoplasia, 2016, 18, 282-293
7.230Citations (PDF)
11Corrigendum to “PIAS1-FAK Interaction Promotes the Survival and Progression of Non–Small Cell Lung Cancer” [Neoplasia 18 (2016) 282-293].
Neoplasia, 2016, 18, 457
7.22Citations (PDF)
12Fatty Acid Oxidation Mediated by Acyl-CoA Synthetase Long Chain 3 Is Required for Mutant KRAS Lung Tumorigenesis
Cell Reports, 2016, 16, 1614-1628
6.4281Citations (PDF)
13Pias1 is essential for erythroid and vascular development in the mouse embryo
Developmental Biology, 2016, 415, 98-110
1.917Citations (PDF)
14Metabolic plasticity maintains proliferation in pyruvate dehydrogenase deficient cells
Cancer & Metabolism, 2015, 3,
4.967Citations (PDF)
15Diet-Induced Unresolved ER Stress Hinders KRAS-Driven Lung Tumorigenesis
Cell Metabolism, 2015, 21, 117-125
27.439Citations (PDF)
16Nullifying the <i>CDKN2AB</i> Locus Promotes Mutant K-ras Lung Tumorigenesis
Molecular Cancer Research, 2014, 12, 912-923
3.543Citations (PDF)
17PML Degradation: Multiple Ways to Eliminate PML
Frontiers in Oncology, 2013, 3,
2.721Citations (PDF)
18RHOA-FAK Is a Required Signaling Axis for the Maintenance of KRAS-Driven Lung Adenocarcinomas
Cancer Discovery, 2013, 3, 444-457
25.6109Citations (PDF)
19The SUMO E3-ligase PIAS1 Regulates the Tumor Suppressor PML and Its Oncogenic Counterpart PML-RARA
Cancer Research, 2012, 72, 2275-2284
0.6115Citations (PDF)
20Translation‐dependent mechanisms lead to PML upregulation and mediate oncogenic K‐RAS‐induced cellular senescence
EMBO Molecular Medicine, 2012, 4, 594-602
7.329Citations (PDF)
21Treatment with 5-Azacytidine Accelerates Acute Promyelocytic Leukemia Leukemogenesis in a Transgenic Mouse Model
Genes and Cancer, 2011, 2, 160-165
3.82Citations (PDF)
22Successful Treatment of Relapsed and Refractory Extramedullary Acute Promyelocytic Leukemia With Tamibarotene
Journal of Clinical Oncology, 2011, 29, e534-e536
21.616Citations (PDF)
23Dual Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Blockade Is an Effective Radiosensitizing Strategy for the Treatment of Non–Small Cell Lung Cancer Harboring <i>K-RAS</i> Mutations
Cancer Research, 2009, 69, 7644-7652
0.6141Citations (PDF)
24A CK2-Dependent Mechanism for Degradation of the PML Tumor Suppressor
Cell, 2006, 126, 269-283
34.4278Citations (PDF)
25The Mechanisms of PML-Nuclear Body Formation
Molecular Cell, 2006, 24, 331-339
13.7493Citations (PDF)
26In vivo analysis of the role of aberrant histone deacetylase recruitment and RARα blockade in the pathogenesis of acute promyelocytic leukemia
Journal of Experimental Medicine, 2006, 203, 821-828
8.043Citations (PDF)
27Loss of the Tumor Suppressor PML in Human Cancers of Multiple Histologic Origins
Journal of the National Cancer Institute, 2004, 96, 269-279
4.8315Citations (PDF)
28Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective
Hepatology, 1998, 27, 628-633
10.3370Citations (PDF)
29Biologic Properties of Hepatitis B Viral Genomes with Mutations in the Precore Promoter and Precore Open Reading Frame
Virology, 1997, 233, 374-381
2.3157Citations (PDF)
30Recent advances in the molecular biology of hepatitis B virus
Bailliere's Clinical Gastroenterology, 1996, 10, 207-225
1.439Citations (PDF)
31Characterization of Hepatitis B Virus Core Mutants That Inhibit Viral Replication
Virology, 1994, 205, 112-120
2.358Citations (PDF)
32Conserved core protein sequences in hepatitis B virus infected patients without anti-HBc
Journal of Hepatology, 1991, 13, 187-191
3.626Citations (PDF)
33Hepatitis B virus infection of peripheral blood mononuclear cells is common in acute and chronic hepatitis
Journal of Medical Virology, 1990, 31, 135-140
3.834Citations (PDF)
34Detection of hepatitis B virus transcripts in patients with chronic liver disease
Journal of Hepatology, 1990, 10, 180-185
3.62Citations (PDF)